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Abstract
Clostridium difficile is the most common cause of antibiotic-associated diarrhoea in hospitals and other healthcare facilities.
The elderly are particularly susceptible and at increased risk for adverse outcome as a result of C. difficile infection. The aim
of this study was to determine the prevalence of C. difficile colonization among residents of nursing homes in Hesse and to
compare it with the prevalence in the general population living outside long-term care facilities (LTCF). We assessed
possible risk factors for C. difficile colonization and determined the genotype of circulating strains. C. difficile was isolated
from 11/240 (4.6%) nursing home residents and 2/249 (0.8%) individuals living outside LTCF (p=0.02). Ten of 11 (90.9%)
isolates from nursing homes and one of two isolates from the population outside LTCF were toxigenic. The prevalence of C.
difficile colonization varied from 0% to 10% between different nursing homes. Facilities with known actual or recent CDI
cases were more likely to have colonized residents than facilities without known CDI cases. C. difficile PCR-ribotypes 014
and 001 were the most prevalent genotypes and accounted for 30% and 20% of toxigenic isolates in nursing homes,
respectively. Interestingly, no individuals carried the epidemic strain PCR-ribotype 027. Our results suggest that residents of
nursing homes in Germany are at high risk for colonization by virulent C. difficile strains. The high prevalence of C. difficile
colonization in nursing homes underscores the importance of good adherence to standard infection control precautions
even in the absence of a diagnosed infection. They also emphasize the need for specific programs to increase the awareness
of healthcare professionals in LTCF for CDI.
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Introduction
Clostridium difficile infection (CDI) caused by an anaerobic, gram-
positive, spore-forming bacillus is the most common cause of
healthcare-associated infectious diarrhoea in healthcare facilities.
There is a strong association between antimicrobial therapy and
CDI, as C. difficile can only colonize the gut if the normal intestinal
flora is disturbed or absent [1]. The incidence and severity of CDI
has markedly increased over the last 10–15 years. This has been
attributed to multiple factors including changing demographic
situation, increased use of broad-spectrum antibiotics and
emergence of hypervirulent C. difficile strains [2].
The elderly are particularly susceptible and at increased risk
for adverse outcomes as a result of CDI [3,4]. The increased risk
of acquiring C. difficile infection in the elderly may be due to age-
related changes in faecal flora, immune senescence, or the presence
of other underlying diseases [4]. Recently, several outbreaks of CDI
have been reported from nursing homes in different European
countries and the USA [5,6,7,8]. Little is known about the
incidence, prevalence, and molecular epidemiology of CDI in
nursing homes in the absence of an epidemic situation [9,10]. To
our knowledge, this is the first study on prevalence of C. difficile
among nursing home residents in Germany.
In this survey, we studied the prevalence of C. difficile
colonization among residents of different nursing homes in Hesse,
a state with approximately six Million inhabitants located in
Southwest Germany. For comparison, we determined the rate of
C. difficile colonization in the general population living outside
nursing homes in the same geographic region. We evaluated
which factors were associated with C. difficile colonization. The
C. difficile isolates were tested for toxin production and further
characterized by PCR-ribotyping to determine their genetic
relationship and to evaluate the distribution of epidemic
genotypes.
Results
Using a cross-sectional design, we studied the prevalence of
intestinal colonization by C. difficile among 240 nursing home
residents and 249 volunteers living outside LTCF in Hesse. A
summary of demographic and anamnestic information of the
participants is presented in Table 1. The groups differed in terms of
age,witha meanage of83yearsinnursinghomeresidentsversus51
years in the population outside LTCF (Figure 1). The majority of
participants were female. The history of hospital admission and
antibiotic therapy during previous three months, and prevalence of
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residents and the population outside LTCF (Table 1).
C. difficile was isolated from 11 (4.6%) of 240 nursing home
residents and two (0.8%) of 249 participants living outside LTCF
(p=0.02). Ten (90.9%) of 11 isolates obtained from the nursing
home residents and one of two isolates from the population outside
LTCF were toxigenic, as determined by ELISA and PCR. Thus,
ten (4.2%) of 240 nursing home residents and one (0.4%) of 249
Figure 1. Age structure of participants from nursing home (A) and general population (B). Participants colonized by toxigenic C. difficile
are shown in dark blue.
doi:10.1371/journal.pone.0030183.g001
Table 1. Summary of Demographic and anamnestic information about the participants from nursing homes and the general
population outside LTCF.
Condition Nursing home residents General population p
Age, range, yr 38–100 16–90 ,0.01
Age, mean, yr 83 51 ,0.01
Age, median, yr 85 52 ,0.01
Male, n/total* (%) 52/239 (21.8) 97/248 (39.1) ,0.01
Hospital Admission during previous three months, n/total* (%) 35/240 (14.6) 30/226 (13.3) 0.68
Antimicrobial therapy during previous three months, n/total* (%) 40/240 (16.7) 32/226(14.2) 0.45
Diarrhoea at study time, n/total* (%) 7/240 (2.9) 5/226 (2.2) 0.63
*Total number of participants with available information.
doi:10.1371/journal.pone.0030183.t001
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difficile isolates (p=0.01).
The prevalence of C. difficile colonization varied from 0% to
10% between different nursing homes (Table 2). The colonization
rate was 10% in two facilities and 9.1% in another nursing home.
Molecular characterization of the isolates revealed that the PCR-
ribotypes (RT) 014 and 001 were the most prevalent genotypes in
nursing homes, accounting for 30% and 20% of toxigenic isolates,
respectively. Other ribotypes including 015, 045, 046, RKI-57,
216 were detected only once each. We did not find any case of
colonization by the presumably hypervirulent strains RT 027 or
078 in this study. When two or three residents in one facility were
colonized by C. difficile, the associated isolates were always assigned
to different ribotypes (Table 2).
The toxigenic C. difficile isolate from the population outside
LTCF was assigned to RT 070. It was recovered from a 28-years-
old woman who had received three cycles of antimicrobial therapy
for recurrent urinary tract infection. She had no history of recent
hospital admission and had no diarrhoea at the time of sample
collection.
Factors associated with C. difficile colonization of nursing home
residents were evaluated by comparing colonized residents with
those who were not colonized (Table 3). There was no apparent
association between colonization and age, contact within previous
four weeks with a person with diarrhoea, dementia, and
incontinence (urine or feces). Previous CDI, previous antibiotic
therapy and previous hospital admission were significantly
associated with colonization by toxigenic C. difficile in nursing
home residents (p#0.01, Table 3).
Together, colonization by toxigenic C. difficile was observed
among residents of seven of eleven nursing homes (Table 2).
According to the information obtained by the questionnaire about
structure and history of CDI in the nursing home, there was only
one case of CDI known in one facility (nursing home A) at the time
of sample collection. CDI cases at the sampling time or during the
previous six months were reported from four facilities (nursing
homes A, D, E, I; seven residents). All these facilities were tested
positive for colonized residents (Table 2). Seven facilities had
reported no actual or recent cases of CDI. Among these, three
were positive for residents colonized by toxigenic isolates, and four
were negative. According to the information obtained from the
facilities’ care management, specific infection control and
management guidance for CDI were available in eight nursing
homes (Table 2).
Discussion
The aim of this study was to determine the prevalence and
molecular epidemiology of C. difficile colonization among nursing
home residents in Hesse, and to compare it with the general
population living outside LTCF in the same geographic region. It
is noteworthy that latter group did not contain elderly people only,
but was representative for the adult population of Hesse. The
proportion of elderly individuals ($65 years) was 17.7% in our
study. In comparison, according to the population pyramid age
structure, 19.7% of the population in Hesse was $65 years in 2008
(Figure S1). Taking into account that a considerable proportion of
elderly people lives in nursing homes in Germany (and is thus
encountered in the nursing home group), we believe that the
composition of the control group is realistic in our study. We found
a similar rate of colonization by avirulent C. difficile isolates in both
groups (0.4%). In contrast, colonization by toxigenic C. difficile
isolates was ten-times higher in nursing home residents than in
the population outside LTCF (4.2% versus 0.4%, p=0.01). These
results suggest that (i) nursing home residents are more likely to be
colonized by C. difficile than the general population outside LTCF,
and (ii) nursing home residents are preferentially exposed to
toxigenic C. difficile strains as compared with population outside
LTCF.
Increasing age, recent exposure to antimicrobial agents, and
recent hospital admission have previously been described as
risk factors for acquisition of C. difficile and development of CDI
[1,4,9,11,12,13,14]. In our study, the groups differed in terms of
age, which is not surprising, because the average age is currently
45 years in the general population in Germany (Figure S1),
whereas nursing home residents are mostly elderly individuals.
They did not differ in terms of history of previous antibiotic
therapy or hospital admission, which is surprising at first glance.
This may be due to the composition of the control group which
also included individuals who attended a general practitioner’s
Table 2. Prevalence of C. difficile colonization and characteristics of the isolates obtained from 240 nursing home residents in
Hesse, Germany.
Nursing
home
Specimens
examined
C. difficile
positive, n (%)
Toxigenic culture
positive, n (%)
PCR-
ribotype
CDI case in facility
at study time
CDI case in facility during
previous 6 months
Specific infection control
guidance available for CDI
A 39 1 (2.6) 1 (2.6) 046 yes yes no
B 16 1 (6.3) 1 (6.3) 001 no no yes
C 17 1 (5.9) 0 031 no no yes
D 30 3 (10) 3 (10) 014, 045,
RKI-57
no yes yes
E 10 1 (10) 1 (10) 001 no yes no
F 24 1 (4.2) 1 (4.2) 015 no no yes
G 12 0 0 no no yes
H 28 0 0 no no yes
I 22 2 (9.1) 2 (9.1) 014, 216 no yes no
J 23 1 (4.3) 1 (4.3) 014 no no yes
K 19 0 0 no no yes
Total 240 11 (4.6) 10 (4.2) 1 (9) 4 (36) 8 (73)
doi:10.1371/journal.pone.0030183.t002
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enrolled by the latter route was less than 10%. Another possible
explanation is that people with potential risk factors such as
antibiotic pre-treatment and prior hospitalisation were more easily
motivated to participate in this study. Nonetheless, this does not
seem to have a noticeable impact on the outcome, since the
prevalence of C. difficile in the population outside LTCF was very
low. In summary, our results indicate that the combination of high
age and living in a nursing home is a significant risk factor for
colonization by toxigenic C. difficile. However, since our control
group included the entire adult population and not only elderly
people living outside nursing homes, we can not asses the influence
of the factors high age and living in a nursing home alone.
Our data are in accordance with studies from the United
Kingdom and the USA, which revealed a prevalence of 0–20% for
C. difficile colonization in LTCF in the absence of a recognized
outbreak [4,9,15]. Our finding of 0.8% colonization rate among
individuals outside a healthcare facility is lower as recently
reported in a community-dwelling elderly population in the
United Kingdom [16]. In that study, 6 (4%) of 149 samples were
positive, but five of six positive samples were detected by
enrichment culture only. We did not apply an enrichment culture
and our results may therefore underestimate both carriership in
residents of nursing homes and individuals outside LTCF.
Various factors may influence the prevalence of C. difficile in
nursing homes, e.g. differences in the debility of residents,
antibiotic consumption, hospital admission rate, infection control
practise, strain virulence, and in alertness and preparedness of the
facilities for CDI. We found that facilities with actual or recent
cases of CDI were more likely to have colonized residents than
those without known CDI cases. Previous studies have shown that
shedding of C. difficile may persist for several weeks after resolution
of diarrhoea [17]. It is estimated that 15–20% of CDI patients may
experience a recurrence, resulting in prolonged carriership and
shedding [18]. In addition, symptomatic patients with CDI who
remain in the nursing home may represent a source of infection. In
this context, it is important to notice that only 73% of the nursing
homes in our study had specific infection control and management
guidance for CDI, suggesting that additional efforts are required to
further improve the infection control management in nursing
homes in Germany.
Nine different PCR-ribotypes were obtained from the nursing
home residents in this study. The most common ribotypes were 014
and 001, which belong to the most prevalent genotypes among
hospitalized patients with CDI in Germany and in Europe [19,20].
Wedidnotdetectisolatesfrom theepidemicRT027 and078inthis
study, although these strains have been repeatedly isolated from
hospitalized patients with CDI in Hesse and in Germany
[19,21,22,23]. It can be hypothesized that PCR-ribotypes 027
and 078 might be rather associated with infection than colonization
in Germany. However, since the number of isolates collected in this
study was limited, our findings are probably not representative for
the distribution of C. difficile genotypes in nursing homes in
Germany. Further investigation with a larger panel of isolates is
required to evaluate this hypothesis.
The present study is the first survey on prevalence of C. difficile
colonization among nursing home residents in Germany.
Strengths of the study are the inclusion of residents of eleven
nursing homes and a control group representing the general
population outside LTCF. Second, all stool samples were cultured
and C. difficile isolates were characterized by toxin assays and
molecular typing. Our study has also a few limitations. First,
although approximately 500 individuals were enrolled, the
number of collected isolates was rather limited. Second, only
44% of the nursing homes that were asked for participation agreed
and were enrolled. Third, the percentage of residents that
participated in this study varied between 15% and 48% in
different nursing homes (median 31.5%), because not all residents
or their legal guardians agreed with participation, some residents
were not cooperative in terms of collection of stool samples, and
some healthcare professionals were not interested. Therefore, it is
likely that our prevalence data are not representative for all
nursing home residents in Germany, but present a broad outline of
the circulation of C. difficile in nursing homes. Fourth, we do not
have exact data about the incidence of CDI in the nursing homes.
It is noteworthy that medical care for nursing home residents is not
centrally organised by the facility’s management in Germany.
Each resident has his or her own general practitioner, who is in
charge of diagnostic and therapy. This may lead to differences
within a nursing home and also between different facilities with
regard to the frequency of conduction and choice of diagnostic
tests for C. difficile.
Table 3. Characteristics of the nursing home residents in correlation with colonization by toxigenic C. difficile.
Characteristics
Colonized
(n=10)
Not colonized
(n=230)
Prevalence
ratio (95% CI) P
Age (mean) 83.0 82.5 – 0.86
Previous CDI 1 1 13.2 (2.87–62.5) ,0.01
Residence in a nursing home with CDI among residents during previous six months 7 94 3.22 (0.85–12.0) 0.08
Contact to patients with diarrhoea 0 10 – –
Infection/colonization by MRSA or other multiresistant organisms 0 7 – –
Antibiotic therapy in previous three months 5 35 5.00 (1.52–16.4) 0.01
Hospital admission during previous three months 5 30 5.85 (1.79–19.2) ,0.01
Chronic wound 1 8 2.67 (0.37–19.2) 0.33
Percutaneous-oesophageal-gastrotomy feeding tube 2 18 2.75 (0.63–12.0) 0.18
Dementia 4 121 0.61 (0.18–2.12) 0.45
Incontinence, urine 7 181 0.65 (0.17–2.41) 0.53
Incontinence, feces 5 120 0.92 (0.27–3.10) 0.90
The data were evaluated by comparing colonized to not colonized residents and calculating the point prevalence ratio.
doi:10.1371/journal.pone.0030183.t003
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residents in Hesse are at high risk for colonization by toxigenic
C. difficile. The high prevalence of C. difficile colonization in nursing
homes underscores the importance of good adherence to standard
infection control precautions even in the absence of a diagnosed
infection. They also emphasize the need for specific programs to
increase the awareness of healthcare professionals in LTCF for
CDI.
Materials and Methods
Study population
Twenty-five nursing homes located in 20 districts in Hesse were
invited by telephone call, e-mail, and letter to participate in this
study. Participation conditions were: i) the facility had to overtake
all organizing tasks in the nursing home, i.e. information of
personnel, residents and/or their legal guardians, distribution of
information material and collection of the informed consent form,
collection and shipment of faecal samples, and ii) at least 10
residents from each facility should be enrolled. Eleven nursing
homes from different geographic areas (10 districts around Hesse)
and different size (40–120 beds), which were run by different
organisations (e.g. German Red Cross, Church, Foundations and
privately-run) agreed and were enrolled between June 2010 and
May 2011. General information about the facility’s structure and
history of recent CDI cases was collected by a questionnaire which
was filled out by the care manager. Informed consent was obtained
from all participants or their legal guardians. Individual conditions
of participants were evaluated using a questionnaire that was filled
out by the healthcare personnel for each participant.
In parallel, the population outside nursing homes in Hesse was
called on to participate in this study as a control group. An
information campaign was launched by articles in the local press,
posters, flyers, telephone calls, personal visits to institutions
including regional public health offices, municipal and state
administration, clubs and societies, companies, a hairdressers’
saloon, two pharmacies, and a general practitioner’s office. Eligible
were persons of $16 years who were not professionally involved in
patient care or worked in diagnostic laboratories. The participants
completed a short questionnaire and signed the informed consent
form. The study protocol was approved by the Ethic Committee of
the General Medical Council of Hesse.
Collection and transport of stool samples
Faecal samples were collected by the healthcare personnel in the
nursing homes. Residents who had agreed to participate, or for
whom a written agreement was obtained from the legal guardian,
and who were cooperative were enrolled. Samples were stored for
maximal one day at 4–8uC and sent to the laboratory of the Hesse
State Health Office (HSHO) via courier or with the post. Samples
from the general population were either submitted directly to our
laboratory or sent with the post (average transport time: one day).
The transport conditions did not differ considerably between the
groups.
Laboratory investigation
Clostridium cultures were performed on C. difficile selective agar
containing cycloserine, cefoxitin and fructose (Oxoid, Wesel,
Germany) with and without pre-treatment with ethanol (50% (v/v)
final concentration, 1 h, room temperature). The cultures were
incubated at 37uC under anaerobic conditions for 5–6 days and
examined every 2–3 days. Identification was performed by routine
microbiologic techniques and a latex agglutination test for C.
difficile (Microgen, Cambereley, U.K.) [21]. All isolates were tested
for toxin production in vitro by using an ELISA detecting toxin A
and B (Biopharm, Darmstadt, Germany) und for the presence of
C. difficile Toxin B gene (tcdB) by using a PCR-hybridisation assay
(Hyplex, Gießen, Germany) according to the manufacturer’s
recommendations.
PCR-ribotyping
Ribotyping was performed at the Robert Koch Institute in
Wernigerode, in the HSHO, or in the Department of Medical
Microbiology, Leiden University Medical Center, according the
protocol of Bidet et al. [24], except that PCR Products were run
on 1.5% agarose gel at 85 volts for 4 hours. Isolates were assigned
novel ribotypes (RT) if their patterns differed from previously
named patterns by at least one band.
Statistical analysis
Participants’ characteristics were compared with the Chi-square
test, Fishers exact test and t-test as appropriate. Point prevalence
ratios with accompanying 95% confidence interval (CI) were
calculated to assess which characteristics were associated with
colonization. Results were considered statistically significant when
the 2-sided P value was ,0.05. Statistical analysis was performed
with PASW Statistics version 17.0 (SPSS Inc., Chicago, USA).
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